Methadone Treatment in Primary Care: Experience from Ontario, Canada 1980-2021
Webinar – Wednesday, May 31st @ 7pm ET Lori Regenstreif, MD Andrew McLeod Meldon Kahan, MD As the United States…
NYSAM
About NYSAM
The New York Society of Addiction Medicine is a physician-led professional community committed to the advancement of evidence-based addiction science and care. Together, we can overcome substance use disorders and the disease of addiction.
May 1, 2023 by NYSAM
New OASAS Medical Advisory Panel (MAP) Xylazine Guidance
OASAS has posted the new OASAS Medical Advisory Panel (MAP) Xylazine Guidance document. Please share widely with your staff. Please…
April 26, 2023 by NYSAM
Pilot Funding Opportunity: One Year Up to $75,000 for Research
One year of pilot funding of up to $75,000 for research into chronic pain and opioid use disorder IMPOWR-ME is…
April 17, 2023 by NYSAM
Learning Session May 1st – Evidence for the Use of PrEP
Please join us for our upcoming General Membership Learning Session, scheduled for Monday, May 1st from 8-9PM. Pamela Mund, MD,…
March 30, 2023 by NYSAM
NYSPA Addictions Division In-Person Conference
Join The Division on Addictions of the New York State Psychological Association (NYSPA) and the Concentration in Mental Health and…
March 30, 2023 by NYSAM
FDA Approves Over-the-Counter Naloxone
On March 29th, the the U.S. Food and Drug Administration (FDA) approved the first nonprescription, “over-the-counter” (OTC) naloxone nasal spray, Narcan. This…
- Go to page 1
- Go to page 2
- Go to page 3
- Interim pages omitted …
- Go to page 11
- Go to Next Page »